Vacation nightmare: 12 family members diagnosed with fungal disease after exploring Costa Rica cave
The family that is spread across three states — Georgia, Texas and Washington — returned home feeling sick after a recent vacation.
According to the Centers for Disease Control, on January 17, 2025, a Georgia infectious disease physician notified CDC of suspected histoplasmosis cases.
Prior to the report, the family had visited the Venado Caves in Costa Rica, which was linked to a previous histoplasmosis outbreak.
While there were 13 family members traveling on December 21–28, only 12, six adults aged 42–49 and six children aged 8–16, who visited the cave were diagnosed with histoplasmosis.
Histoplasmosis is defined by the CDC as a fungal infection that primarily affects the lungs.
Histoplasmosis is caused by Histoplasma organisms, which are often found in soil contaminated with bird or bat droppings.
The condition is often misdiagnosed, as it was in this particular case.
One adult went to an emergency room and was hospitalized because of an abnormal chest radiography.
The findings raised concerns about lung cancer.
All 12 members who toured the cave became ill after 8-19 days of the exposure.
Family members experienced headaches, malaise, fever, night sweats, myalgias, and respiratory and gastrointestinal symptoms.
They all recovered to full health 28 days after exposure.
The Venado Caves in Costa Rica are also associated with another histoplasmosis outbreak in 1998–1999 that affected 51 people.
In response to this outbreak, the CDC alerted health departments through an Epidemic Information Exchange notification to help identify additional cases.
The CDC has been collaborating with the U.S. Embassy in Costa Rica and the Costa Rican Ministry of Health to incorporate information about histoplasmosis risks into the caving tour's waiver forms.
In addition, the U.S. Embassy in Costa Rica issued a health alert in March 2025 notifying the public of the risk of contracting histoplasmosis from the cave tours.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Texas A&M mascot Reveille has eye removed after glaucoma diagnosis
Texas A&M announced Wednesday that Reveille X, the school's mascot, had to have an eye removed during surgery after she was diagnosed with glaucoma. The collie has served as A&M's mascot since April 30, 2021, when Reveille IX retired. Reveille is a central part of gameday activities at Texas A&M and runs out on the field ahead of home games before taking her normal spot on the sidelines. 'Under the watchful eye of her Mascot Corporals, it came to our attention that Miss Rev has been experiencing some discomfort and cloudiness in her right eye,' A&M president Mark Welsh said in a statement. Sadly, the issue has progressed and during a recent check-up, she was diagnosed with glaucoma. At the recommendation of our world-class veterinarians at the Texas A&M Veterinary Medical Teaching Hospital, Miss Rev underwent surgery earlier [Wednesday] to relieve any discomfort. During surgery, the veterinary team discovered signs of abnormal tissue, and out of an abundance of caution, removed her eye. The tissue was sent to an ocular pathologist for evaluation, which is standard practice.' Welsh said in his statement that Reveille would not make any public appearances while she recovers from her surgery, but that the school 'can expect Miss Rev to be back to enjoying all her favorite activities — cruising on Rev Force One, attending classes, cheering on the Aggies, and keeping our campus squirrels in line - this fall.' The first Reveille was adopted by A&M students in the 1930s and the mascot is officially listed as the highest-ranking member of school's Corps of Cadets. Members of the corps take care of Reveille and she goes everywhere with her caretakers and she's the only non-service dog allowed on campus building. According to Texas A&M tradition, if Reveille barks during a class she's in, the class is canceled.
Miami Herald
an hour ago
- Miami Herald
Covid-19 drug company liquidates assets in Chapter 11 bankruptcy
When the Covid-19 public health crisis began in the U.S. with the first confirmed case of the 2019 Novel Coronavirus in Washington state on Jan. 20, 2020, the terrifying pandemic was underway, and the Centers for Disease Control and Prevention would report its first confirmed death from the virus on Feb. 29. By March 3, 2020, CDC reported 60 confirmed cases in 12 states. On March 13, the first Trump administration declared a national emergency, and states started implementing shutdowns on March 15, according to the CDC's timeline of Covid-19 events. Don't miss the move: Subscribe to TheStreet's free daily newsletter Biotechnology firms Pfizer-BioTech and Moderna Therapeutics began developing Covid-19 vaccines in March 2020, and by November 2020, each company's Covid-19 vaccine would be found 95% effective in clinical trials. Related: CVS rival pharmacy chain files for Chapter 11 bankruptcy Another biotech firm, Regeneron, in November received approval of an antibody treatment to significantly reduce virus levels within days. In December 2020, Covid-19 vaccinations began, and by Dec. 24, 1 million people had been vaccinated in the U.S. CDC said that by June 1, 2022, the U.S. reported over 84 million Covid-19 infections and over 1 million deaths. About a year later, Pfizer reported on its website that on May 5, 2023, the World Health Organization declared an end to the Covid-19 public health emergency, while the U.S. Department of Health & Human Services did the same on May 11, 2023. The healthcare industry's response to the Covid-19 pandemic was so effective that beginning on May 1, 2024, hospitals were no longer required to report Covid-19 hospital admissions, hospital capacity, or hospital occupancy data to the U.S. Department of Health & Human Services through the Centers for Disease Control and Prevention's National Healthcare Safety Network, according to the CDC website. The end of the crisis also ended the need for massive amounts of Covid-19 drugs. With the Covid-19 pandemic subsiding, companies that stepped forward to develop vaccines, drugs, and treatments during the crisis are now facing declining demand for their services to develop Covid-19 products. With no dire need for Covid-19 products, some drug companies have been forced to downsize or even shut down operations because of a lack of business opportunities. Essential drug manufacturer Aluchua Government Services Inc., which developed Covid-19 therapy drugs under U.S. government contracts, has filed for Chapter 11 bankruptcy with plans to wind down operations and sell its assets. Related: Giant healthcare company files Chapter 11 bankruptcy seeking sale The Aluchua, Fla.-based pharmaceutical company filed its petition in the U.S Bankruptcy Court for the District of Delaware, listing $50 million in assets and $100 million to $500 million in liabilities. The debtor's largest creditors include United States International Development Finance Corp., owed $246 million; Defense Contract Management Agency, owed $11.95 million; and Sigma-Aldrich Inc. $1.33 million. Aluchua was founded in 1999 to develop new drugs and to increase efficacy of existing ones. In 2013, it was awarded a greenfield contract with the U.S. Department of Defense, and in February 2020, it was awarded a contract to develop an advanced monoclonal antibody therapy against Covid-19 infection. The Covid-19 drug was one of several that the debtor partnered with the U.S. government to develop and produce drugs, vaccines, and treatments. The debtor needed to file for Chapter 11 protection after demand for its services began to decline in late 2023 and certain government contracts were wound down or scaled back, according to Aluchua's Chief Restructuring Officer Janet R. Naifeh of FTI Consulting Inc. Aluchua's efforts to replace its government business with commercial contracts failed, which forced it to scale down production and lay off 125 employees from January through April 2025. It reduced its staff by another 67 employees on June 20 and July 1, which, combined with the earlier layoffs, amounted to termination of 80% of its workforce. The company employed 13 full-time and three temporary workers as of the petition date. The company marketed itself for sale beginning in February 2025, but was unable to complete a transaction and decided its only viable option was to file for Chapter 11 bankruptcy, wind down its business, and sell its assets. Related: Iconic retail chain closing its remaining stores in bankruptcy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Axios
an hour ago
- Axios
RFK Jr. greenlights removing preservative from flu shots
The Health and Human Services Department on Wednesday said it adopted a recommendation from Secretary Robert F. Kennedy Jr.'s vaccine advisers to remove from all influenza shots a preservative that anti-vaccine activists have suggested is linked to autism. Why it matters: The move hinged on the widely discredited belief that the mercury-containing compound, thimerosal, is harmful at the level at which it's included in vaccines. Despite the lack of evidence of harm, most Americans who get flu vaccines already receive products without thimerosal. The latest: Kennedy, in a statement, said the action fulfilled a promise to protect vulnerable populations from unnecessary mercury exposure. "Injecting any amount of mercury into children when safe, mercury-free alternatives exist defies common sense and public health responsibility," Kennedy said. "Today, we put safety first." The Centers for Disease Control customarily acts on such recommendations. But because the CDC lacks a full-time political leader, Kennedy signed the recommendation. HHS said that vaccine manufacturers confirmed that they have the capacity to replace multi-dose vials containing the preservative so that the federal Vaccines for Children program and adult vaccine supplies won't be interrupted. Kennedy's handpicked vaccine advisors voted 5-1 last month to no longer recommend that that Americans get flu shots containing thimerosal, following a presentation from a retired nurse and former president of Children's Health Defense, the anti-vaccine group with close ties to Kennedy.
